Cyclophosphamide in lupus nephritis: a controlled trial

Ann Intern Med. 1971 Aug;75(2):165-71. doi: 10.7326/0003-4819-75-2-165.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Antibodies, Antinuclear / analysis
  • Biopsy
  • Child
  • Clinical Trials as Topic
  • Complement System Proteins / analysis
  • Creatinine / blood
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • DNA
  • Female
  • Hematuria / complications
  • Humans
  • Immunoglobulin A / analysis
  • Immunoglobulin G / analysis
  • Kidney / pathology
  • Leukocyte Count
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy
  • Nephritis / complications
  • Nephritis / diagnosis
  • Nephritis / drug therapy*
  • Neutrophils
  • Placebos
  • Prednisone / administration & dosage
  • Prednisone / therapeutic use
  • Proteinuria / complications
  • Pyuria / complications
  • Time Factors
  • Urine / cytology
  • gamma-Globulins / analysis

Substances

  • Antibodies, Antinuclear
  • Immunoglobulin A
  • Immunoglobulin G
  • Placebos
  • gamma-Globulins
  • Cyclophosphamide
  • Complement System Proteins
  • DNA
  • Creatinine
  • Prednisone